longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Virax Biolabs(VRAX.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Pre-market hot trades in US stocks: Virax Biolabs pre-market up 31.91%; PulteGroup pre-market down 16.78%

Price Alert·1 Hours ago
US
VRAX
+53.09%
US
PHM
+1.52%
Price Alert·1 Hours ago
US
VRAX
+53.09%
US
PHM
+1.52%

Why Is Virax Biolabs (VRAX) Stock Trending Overnight?

fidelity·4 Hours ago
US
VRAX
+53.09%
US
FBT
-0.66%
US
SBIO
-3.43%
fidelity·4 Hours ago
US
VRAX
+53.09%
US
FBT
-0.66%
US
SBIO
-3.43%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·Yesterday at 20:05
US
GOSS
-43.32%
US
LTRN
-4.46%
US
AIM
+61.26%
benzinga_article·Yesterday at 20:05
US
GOSS
-43.32%
US
LTRN
-4.46%
US
AIM
+61.26%

Virax Mulls Bringing UK Biotech Startup’s Immune Profiling Platform to China, Chair Says

Yicai·05/11/2026 16:01
US
VRAX
+53.09%
Yicai·05/11/2026 16:01
US
VRAX
+53.09%

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders | VRAX Stock News

StockTitan·04/14/2026 11:35
US
VRAX
+53.09%
US
PBE
-0.58%
US
FBT
-0.66%
StockTitan·04/14/2026 11:35
US
VRAX
+53.09%
US
PBE
-0.58%
US
FBT
-0.66%

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga_article·04/14/2026 01:05
US
ONCO
-18.26%
US
RVMD
-0.89%
US
VRAX
+53.09%
benzinga_article·04/14/2026 01:05
US
ONCO
-18.26%
US
RVMD
-0.89%
US
VRAX
+53.09%
© 2026 Longbridge|Disclaimer

Event Tracking

May11
Virax Biolabs Considers Introducing T-Cell Immune Analysis Platform to China
08:04
Dec3
Virax Biolabs Group Ltd Completes First UK Clinical Trial Recruitment and Advances Scientific Dossier
12:34
Virax Biolabs released FY2026 Semi-Annual earnings on December 2, 2025 (EST) with actual revenue of USD 1.608 K and EPS of USD -0.491
04:00
Virax Biolabs released FY2026 Q2 earnings on December 2, 2025 (EST), actual revenue USD 804 (forecast USD 10 K), actual EPS USD -0.2455 (forecast USD -0.34)
04:00
Virax Biolabs released FY2026 Q1 earnings on December 2, 2025 (EST), actual revenue USD 804 (forecast USD 10K), actual EPS USD -0.2455 (forecast USD -0.34)
04:00
Nov3
Virax Biolabs Group Ltd. Completes UK Clinical Study and Plans US Research in 2026
13:30

Schedules & Filings

Schedules
Filings
Dec2
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 804, Net Income -1.169 M, EPS -0.2455

Jul2
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 689, Net Income -1.652 M, EPS -0.3792

Nov20
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.476 K, Net Income -1.378 M, EPS -0.4449

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AMPGR
0.2475
+350.00%
+0.193
AMPGZ
0.2500
+150.00%
+0.150
WGRX
0.1740
+108.38%
+0.090
HCAI
11.000
+98.56%
+5.460
GOVX
2.210
+79.67%
+0.980
SBFM
0.5100
+79.51%
+0.226
AIM
0.4080
+61.26%
+0.155
VRAX
0.2350
+53.09%
+0.082
NXXT
0.4100
+46.22%
+0.130
GCTS
2.580
+40.98%
+0.750
View More